A strategic investor AGEL Group has entered into a clinical genetics company at Prague 8.

NEWTON Business Development, a.s., provided its advisory services at the strategic investor’s entry – Laboratoře AGEL a.s. – into a company GENETIKA – ZENKLOVA s.r.o., which operates clinical genetics at Prague 8. The transfer of 100% share on the company was realized on 18 April, 2017.